A marked decrease in GLUT-1, HK-I, GAPDH, and LDH, and of Kreb’s cycle and OXPHOS enzymes, supports the likelihood that cancer cells use both glycolysis and OXPHOS [41,42], suggesting that metabolism reprogramming is induced by VDAC1 silencing. The gene discussed is SLC2A1; the disease is cancer.